Portfolio Management and Asset Valuation
At BioMed we enhance portfolios with strategies that encompass all facets of drug development. By following our holistic guidance, you can make earlier, quicker, and more informed decisions regarding risk and reward, thus maximizing each asset's potential for success.
Contact Us for integrated expert advice.
Our team comprises specialists in clinical, regulatory, and market access strategy. We evaluate your assets from various perspectives, providing integrated guidance early in development. With thorough and practical strategies, we tackle development hurdles, enabling you to optimize your investments and clinical endeavors.
Navigating the Complexities of Early-Stage Development
We adopt an integrated approach to early-phase studies to help you mitigate multifaceted risks. By employing a unified strategy that considers every facet of development, we facilitate quicker decision making and establish a solid groundwork for later stage work.
Product Development and Consulting across Preclinical, Clinical and Post-Approval pathways.
PRECLINICAL
We create detailed preclinical plans with an eye toward later stages of development for your asset. Our non-clinical regulatory experts specialize in developing plans that satisfy the needs of regulators to move a product to the clinic and beyond.
CLINICAL
Our clinical development consultants are experts in the design and execution of full product development programs. With access to a range of internal experts including physicians, biostatisticians and clinical scientists, our team can help design a development plan that reduces risk and maximizes clinical success.
OPTIMIZING MARKET ACCESS
With rigorous, evolving and heterogeneous payer evaluation criteria, challenging price negotiations, and a dynamic competitive environment, drug developers need to prepare their market access strategy early in the product life cycle to ensure optimal access. Our expert team of industry leaders, former payers, policy experts, and experienced strategists can help you navigate complex evidence requirements, anticipate and overcome payer barriers to help you achieve optimal price and access.
Staying on top of drug safety.
Drug safety and pharmacovigilance professionals are increasingly challenged, having to do more with less. The key to your success is implementing automation, adopting advanced technologies, and leveraging insights from analytics that improve compliance and product safety. BioMed provides flexible, innovative, scalable solutions to meet your unique business requirements.